PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cosentyx

Top Performing Drug – Cosentyx (November Edition)

Top Performing Drug – Cosentyx (November Edition)

November 23, 2023

Novartis' Cosentyx (secukinumab) Receives the NMPA's Approval for the Treatment of Pediatric Psoriasis in China

Novartis' Cosentyx (secukinumab) Receives the NMPA's Approval for the Treatment of Pediatric Psoriasis in China

August 17, 2021

Novartis' Cosentyx (secukinumab) Receives NMPA's (CFDA) Approval for Patients with Plaque Psoriasis in Adults

Novartis' Cosentyx (secukinumab) Receives NMPA's (CFDA) Approval for Patients with Plaque Psoriasis in Adults

April 2, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us